Comparison between Nectar Lifesciences IPO and SPL Industries IPO.
Nectar Lifesciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while SPL Industries IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| Nectar Lifesciences IPO | SPL Industries IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | ICICI Securities Ltd. | Standard Chartered Securities (India) Ltd. Karvy Investor Services Ltd. |
| Registrar | Kfin Technologies Ltd. | Kfin Technologies Ltd. |
| Market Maker | ||
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Nectar Lifesciences IPO is up to ₹92.88 Cr whereas the issue size of the SPL Industries IPO is up to ₹63.00 Cr. The final issue price of Nectar Lifesciences IPO is ₹240.00 per share and of SPL Industries IPO is ₹70.00 per share.
| Nectar Lifesciences IPO | SPL Industries IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹200.00 per share | ₹60.00 per share |
| Issue Price (Upper) | ₹240.00 per share | ₹70.00 per share |
| Issue Price (Final) | ₹240.00 per share | ₹70.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 38,70,000 shares | 90,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹92.88 Cr | up to ₹63.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 38,70,000 shares | 90,00,000 shares |
| Issue Size Total (Amount) | up to ₹92.88 Cr | up to ₹63.00 Cr |
Nectar Lifesciences IPO opens on Jun 22, 2005, while SPL Industries IPO opens on Jun 29, 2005. The closing date of Nectar Lifesciences IPO and SPL Industries IPO is Jun 28, 2005, and Jul 05, 2005, respectively.
Nectar Lifesciences IPO P/E ratio is , as compared to SPL Industries IPO P/E ratio of .
| Nectar Lifesciences IPO | SPL Industries IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 89.08 | 93.86 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 65.93 | 64.73 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 31.3 | 14.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Nectar Lifesciences IPO Retail Individual Investors (RII) are offered 13,54,500 shares while in SPL Industries IPO retail investors are offered 13,54,500 shares. Qualified Institutional Buyers (QIB) are offered 19,35,000 shares in Nectar Lifesciences IPO and 45,00,000 shares in SPL Industries IPO.
| Nectar Lifesciences IPO | SPL Industries IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 19,35,000 shares | 45,00,000 shares |
| NII | 5,80,500 shares | 13,50,000 shares |
| RII | 13,54,500 shares | 31,50,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 38,70,000 shares | 90,00,000 shares |
Nectar Lifesciences IPO subscribed in total, whereas SPL Industries IPO subscribed .
